Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Autism Dev Disord. 2009 May;39(5):720-9. doi: 10.1007/s10803-008-0675-2. Epub 2008 Dec 19.

Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.

Author information

  • 1Child Study Center, Yale University, New Haven, CT 06520, USA. Lawrence.scahill@yale.edu

Abstract

This paper presents the rationale for a 24-week, randomized trial designed to test whether risperidone plus structured parent training would be superior to risperidone only on measures of noncompliance, irritability and adaptive functioning. In this model, medication reduces tantrums, aggression and self-injury; parent training promotes improvement in noncompliance and adaptive functioning. Thus, medication and parent training target related, but separate, outcomes. At week 24, the medication was gradually withdrawn to determine whether subjects in the combined treatment group could be managed on a lower dose or off medication without relapse. Both symptom reduction and functional improvement are important clinical treatment targets. Thus, experimental evidence on the beneficial effects of combining pharmacotherapy and exportable behavioral interventions is needed to guide clinical practice.

PMID:
19096921
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Write to the Help Desk